Bernd Meibohm
Affiliations: | Pharmaceutical Sciences | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Pharmacology, Pharmaceutical ChemistryGoogle:
"Bernd Meibohm"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Nageshwar R. Budha | grad student | 2009 | UTHSC |
| Nathanael L. Dirks | grad student | 2010 | UTHSC |
| V. N. Vaddady | grad student | 2011 | UTHSC |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Temrikar ZH, Suryawanshi S, Meibohm B. (2020) Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients. Paediatric Drugs |
| Fuhr LM, Hanke N, Meibohm B, et al. (2020) Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis. Clinical Pharmacokinetics |
| Shakhnovich V, Meibohm B, Rosenberg A, et al. (2019) Immunogenicity in Clinical Practice and Drug Development: When is it Significant? Clinical and Translational Science |
| Nagesh PKB, Chowdhury P, Hatami E, et al. (2019) Cross linked polyphenol-based drug nano-self assemblies engineered to blockade prostate cancer senescence. Acs Applied Materials & Interfaces |
| Walz A, Lukka PB, Pearce C, et al. (2019) Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies. Tuberculosis (Edinburgh, Scotland). 117: 52-55 |
| Stewart IE, Lukka PB, Liu J, et al. (2019) Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599. Pharmaceutical Research. 36: 136 |
| Donnenberg VS, Chaikin P, Mandic M, et al. (2019) Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Common Problem Drugs and How to Prescribe Them. Journal of Clinical Pharmacology |
| Rathi C, Lukka PB, Wagh S, et al. (2019) Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice. Tuberculosis (Edinburgh, Scotland). 114: 119-122 |
| Vaddady PK, Trivedi A, Rathi C, et al. (2018) Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
| Santos K, Lukka PB, Grzegorzewicz A, et al. (2018) Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular . Frontiers in Microbiology. 9: 1895 |